The US Food and Drug Administration (FDA) has launched a new pilot programme to fast-track abbreviated new drug applications (ANDAs) of generic drugs for companies that make and test them entirely ...

Thanks to new settlement agreements with three generic drug makers, Gilead Sciences has extended the expected life span of its flagship HIV treatment Biktarvy by as many years. Gilead has struck ...

The Malta Medicines Authority has moved to reassure the public over the safety, quality, and effectiveness of generic medicines, following remarks by Opposition Leader Alex Borg suggesting a future ...

Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.

Oct 3 (Reuters) - A drug wholesaler has sued Alkermes (ALKS.O), opens new tab for allegedly maintaining an illegal monopoly over the opioid and alcohol dependence drug Vivitrol, causing buyers to pay ...

Federal regulators have approved a second generic version of the abortion pill mifepristone, a routine step that quickly drew backlash from anti-abortion groups and some Republican lawmakers.

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Evita Solution's generic version of the abortion drug, mifepristone, the regulator said. The FDA said in a letter dated September ...

The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...

The US Food and Drug Administration (USFDA) approved a higher number of generic drugs in FY25, which ended on September 30, than it did in the previous year, signalling a steady appetite for ...

Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...